News Digest / Ticker: RCKT

Ticker: RCKT

07:56am, Tuesday, May 27, 2025

Rocket Pharmaceuticals Faces 57% Plunge After Patient Death in Clinical Trial: What Traders Need to Know

Rocket Pharmaceuticals (NASDAQ: RCKT) sees a 57% premarket drop following a patient death linked to their clinical trial. The FDA has imposed a hold as Rocket reassesses its strategy and financials. Traders face risks, balancing potential recovery against safety concerns.